InvestorsHub Logo
Followers 10
Posts 1864
Boards Moderated 0
Alias Born 06/18/2017

Re: ny3344 post# 11301

Saturday, 03/20/2021 4:54:53 PM

Saturday, March 20, 2021 4:54:53 PM

Post# of 11360
Interesting if they get it.. .''clinical trial strategy is being formulated with focus on the Immunitor V5 FDA Orphan Drug designated HCC candidate, up to US$30 million in development funding is being progressed with a number of interested parties through Key Biotec''